GWANC
MRNA icon

Guardian Wealth Advisors (North Carolina)’s Moderna MRNA Stock Holding History

Guardian Wealth Advisors (North Carolina)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,270
Closed -$323K – 272
2021
Q4 		$323K Buy
+1,270
New +$371K 0.14% 113

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Guardian Wealth Advisors (North Carolina)'s MRNA Position: Q1 2022 in Review

Guardian Wealth Advisors (North Carolina) sold out of Moderna (MRNA) in Q1 2022, closing a stake of 1,270 shares — an estimated $323K sold.

Guardian Wealth Advisors (North Carolina) first reported a position in MRNA in Q4 2021 and held it in 1 quarter. The position peaked at $323K in Q4 2021. 1,007 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • Guardian Wealth Advisors (North Carolina) reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • Guardian Wealth Advisors (North Carolina) sold 1,270 Moderna shares in Q1 2022, an estimated $323K.
  • Guardian Wealth Advisors (North Carolina) first reported a position in Moderna in Q4 2021 and held it in 1 quarter.
  • Guardian Wealth Advisors (North Carolina)'s Moderna position peaked at $323K in Q4 2021.
  • 1,007 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q1 2022, filed 16 May 2022.